Choreo LLC’s Halozyme HALO Stock Holding History

Choreo LLC’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-3,075	Closed	-$208K	–	1657
2025 Q4	$208K	Sell	3,075 -448	-13%	-$30.1K	﹤0.01%	1432
2025 Q3	$258K	Buy	+3,523	New	+$234K	﹤0.01%	1317
2025 Q2	–	Sell	-12,643	Closed	-$807K	–	1556
2025 Q1	$807K	Sell	12,643 -36	-0.3%	-$2.09K	0.01%	633
2024 Q4	$608K	Sell	12,679 -2,293	-15%	-$118K	0.01%	801
2024 Q3	$848K	Buy	14,972 +2,236	+18%	+$128K	0.01%	638
2024 Q2	$663K	Buy	+12,736	New	+$559K	0.01%	683

Other funds holding HALO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Choreo LLC's HALO Position: Q1 2026 in Review

Choreo LLC sold out of Halozyme (HALO) in Q1 2026, closing a stake of 3,075 shares — an estimated $208K sold.

Choreo LLC first reported a position in HALO in Q2 2024 and held it in 6 quarters. The position peaked at $848K in Q3 2024. 634 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

Choreo LLC reported no remaining Halozyme position as of Q1 2026 after selling out during the quarter.
Choreo LLC sold 3,075 Halozyme shares in Q1 2026, an estimated $208K.
Choreo LLC first reported a position in Halozyme in Q2 2024 and held it in 6 quarters.
Choreo LLC's Halozyme position peaked at $848K in Q3 2024.
634 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on Choreo LLC's 13F filing for Q1 2026, filed 13 May 2026.